Optometrist, Corneal and Contact Management · West Covina, CA
NPI
1033152624
Since 2006
Specialty
Optometrist, Corneal and Contact Management
Code 152WC0802X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
236 S Citrus St
West Covina, CA, 91791
Phone (626) 935-8886
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
3,445 services
Medicare patients, 2024
591
Average age 80
Drug cost, 2024
$665K
1,577 prescriptions
Company payments, 2025
$636
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vincent Hsu was code 92060 (vision, hearing, and speech services), 576 times for 566 patients. In total Vincent Hsu billed 3,445 services in 9 codes, and Medicare paid $173K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92060 Vision, Hearing, and Speech Services | Office | 576 | 566 | $49.78 | $29K |
| 92250 Angiography | Office | 575 | 565 | $26.88 | $15K |
| 92285 Standard X-ray | Office | 573 | 563 | $15.67 | $8,977 |
| 92025 Test - Miscellaneous | Office | 552 | 543 | $26.43 | $15K |
| 92014 Ophthalmological E&M | Office | 445 | 434 | $96.51 | $43K |
| 68761 Eye | Office | 378 | 187 | $87.81 | $33K |
| 92012 Ophthalmological E&M | Office | 211 | 189 | $70.77 | $15K |
| 92004 Ophthalmological E&M | Office | 132 | 132 | $109.92 | $15K |
By year: 2022 $191K for 3,438 services; 2023 $182K for 3,314 services; 2024 $173K for 3,445 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vincent Hsu prescribed most often to Medicare patients was Cyclosporine, with 647 prescriptions and refills. In total Vincent Hsu wrote 1,577 Medicare prescriptions that cost $665K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cyclosporine Generic | 647 | 899 | 157 | $259K |
| Restasis Cyclosporine | 356 | 424 | 100 | $265K |
| Zylet Tobramycin/Lotepred Etab | 157 | 170 | 63 | $61K |
| Azelastine Hcl Generic | 87 | 106 | 23 | $1,096 |
| Lumigan Bimatoprost | 62 | 68 | 14 | $16K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 43 | 45 | 19 | $365 |
| Miebo Perfluorohexyloctane/Pf | 32 | 32 | 15 | $24K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 27 | 31 | 15 | $1,361 |
| Eysuvis Loteprednol Etabonate | 17 | 21 | Under 11 | $8,404 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 17 | 19 | Under 11 | $154 |
| Combigan Brimonidine Tartrate/Timolol | 16 | 25 | Under 11 | $4,323 |
| Latanoprost Generic | 14 | 14 | Under 11 | $71.74 |
| Brimonidine Tartrate Generic | 13 | 18 | Under 11 | $2,803 |
| Rhopressa Netarsudil Mesylate | 12 | 12 | Under 11 | $3,544 |
| Bepotastine Besilate Generic | 12 | 17 | Under 11 | $2,115 |
Brand drugs: 1,310 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vincent Hsu $636 ($636 in general payments such as food, travel and fees) from 3 companies. The largest payer was Bausch & Lomb Americas Inc. with $550.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.